These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 31590408)
1. An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy. Lee SW; Lee HY; Bang HJ; Song HJ; Kong SW; Kim YM Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590408 [TBL] [Abstract][Full Text] [Related]
2. The value of human epididymis 4, D-dimer, and fibrinogen compared with CA 125 alone in triaging women presenting with pelvic masses: a retrospective cohort study. McKendry K; Duff S; Huang Y; Redha M; Scanlon Á; Abu Saadeh F; Gleeson N; O'Leary J; Norris L; O'Toole S Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1239-1247. PubMed ID: 33590896 [TBL] [Abstract][Full Text] [Related]
3. Development of a multimarker assay for early detection of ovarian cancer. Yurkovetsky Z; Skates S; Lomakin A; Nolen B; Pulsipher T; Modugno F; Marks J; Godwin A; Gorelik E; Jacobs I; Menon U; Lu K; Badgwell D; Bast RC; Lokshin AE J Clin Oncol; 2010 May; 28(13):2159-66. PubMed ID: 20368574 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses. Dewan R; Dewan A; Jindal M; Bhardawaj M Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718 [TBL] [Abstract][Full Text] [Related]
6. Urinary concentrations of human epidydimis secretory protein 4 (He4) in the diagnosis of ovarian cancer: a case--control study. Macuks R; Baidekalna I; Donina S Asian Pac J Cancer Prev; 2012; 13(9):4695-8. PubMed ID: 23167404 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay. Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses. Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages. Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337 [TBL] [Abstract][Full Text] [Related]
10. Serum Human Epididymis Protein-4 (HE4) - A novel Approach to Differentiate Malignant Frombenign Breast Tumors. Sai Baba KSS; Rehman MA; Pradeep Kumar J; Fatima M; Raju GSN; Uppin SG; Mohammed N Asian Pac J Cancer Prev; 2021 Aug; 22(8):2509-2507. PubMed ID: 34452565 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy and Optimal Cutoff Value of Serum HE4 to Predict Ovarian Cancer in Thai Women with Pelvic Masses. Yanaranop M; Tiyayon J; Nakrangsee S; Thinkhamrop B J Med Assoc Thai; 2016 Dec; 99(12):1263-71. PubMed ID: 29952496 [TBL] [Abstract][Full Text] [Related]
12. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study. Wu L; Chen X; Peng T; Tang E; Bai W; Chen L Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis. Wu L; Dai ZY; Qian YH; Shi Y; Liu FJ; Yang C Int J Gynecol Cancer; 2012 Sep; 22(7):1106-12. PubMed ID: 22854652 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis. Dayyani F; Uhlig S; Colson B; Simon K; Rolny V; Morgenstern D; Schlumbrecht M Int J Gynecol Cancer; 2016 Nov; 26(9):1586-1593. PubMed ID: 27540691 [TBL] [Abstract][Full Text] [Related]
15. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population. Richards A; Herbst U; Manalang J; Pather S; Saidi S; Tejada-Berges T; Tan K; Williams P; Carter J Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):493-7. PubMed ID: 26172511 [TBL] [Abstract][Full Text] [Related]
16. Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses? Yanaranop M; Anakrat V; Siricharoenthai S; Nakrangsee S; Thinkhamrop B Gynecol Obstet Invest; 2017; 82(1):47-53. PubMed ID: 27197526 [TBL] [Abstract][Full Text] [Related]
17. HE4 might be a more useful tumor biomarker to detect malignancy in patients with ovarian endometrioma when malignancy is suspected. Rius M; Fusté P; Ros C; Martínez-Zamora Á; deGuirior C; Gracia M; Mension E; Carmona F J Int Med Res; 2021 Sep; 49(9):3000605211047701. PubMed ID: 34590878 [TBL] [Abstract][Full Text] [Related]
18. A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer. Stiekema A; Lok CA; Kenter GG; van Driel WJ; Vincent AD; Korse CM Gynecol Oncol; 2014 Mar; 132(3):573-7. PubMed ID: 24418200 [TBL] [Abstract][Full Text] [Related]
19. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses. Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698 [TBL] [Abstract][Full Text] [Related]
20. [Establishment and validation of a prediction model for early-stage epithelial ovarian cancer based on LASSO regression]. Luo HJ; Wang SJ; Zhang XF; Tian WY; Luo W; Dong ZL Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(23):2167-2172. PubMed ID: 38871475 [No Abstract] [Full Text] [Related] [Next] [New Search]